Zazpe, Arturo <br/><br/>
In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.  [electronic resource] 

 -  Neuropharmacology  Jul 2006 
 - 129-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2006.03.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>5-Hydroxytryptophan--pharmacology<br/>Animals<br/>Antiparkinson Agents--pharmacology<br/>Antipsychotic Agents--pharmacology<br/>Apomorphine--pharmacology<br/>Avoidance Learning--drug effects<br/>Binding, Competitive--drug effects<br/>Catalepsy--chemically induced<br/>Dopamine Agonists--pharmacology<br/>Dopamine D2 Receptor Antagonists<br/>Dopamine Plasma Membrane Transport Proteins--metabolism<br/>Drug Interactions<br/>Guanosine 5'-O-(3-Thiotriphosphate)--metabolism<br/>Haloperidol--antagonists & inhibitors<br/>Head Movements--drug effects<br/>Hypothermia--chemically induced<br/>Jaw--physiology<br/>Male<br/>Mice<br/>Motor Activity--drug effects<br/>Piperazines--metabolism<br/>Pyridazines--pharmacology<br/>Pyridines--metabolism<br/>Rats<br/>Rats, Wistar<br/>Receptor, Serotonin, 5-HT1A--drug effects<br/>Receptors, Dopamine D2--metabolism<br/>Serotonin Antagonists--metabolism<br/>Serotonin Receptor Agonists--pharmacology<br/>Tremor--physiopathology